Trimazosin
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(2-hydroxy-2-methylpropyl) 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate | |
| Identifiers | |
| CAS Number |
53746-46-6 |
| ATC code | C02CA03 (WHO) |
| PubChem | CID 37264 |
| ChemSpider |
34203 |
| UNII |
31L760807H |
| ChEMBL |
CHEMBL513301 |
| Chemical data | |
| Formula | C20H29N5O6 |
| Molar mass | 435.47 g/mol |
| |
| |
| | |
Trimazosin is a sympatholytic alpha blocker.[1][2]
References
- ↑ van Kalken CK, van der Meulen J, Oe PL, Vriesendorp R, Donker AJ (1986). "Pharmacokinetics of trimazosin and its effects on blood pressure, renal function and proteinuria during short-term therapy of patients with impaired renal function and hypertension". Eur. J. Clin. Pharmacol. 31 (1): 63–8. doi:10.1007/BF00870988. PMID 3780829.
- ↑ U.S. Patent 3,669,968
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
